Strides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2025 ,inter alia, to consider and approve This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Tuesday, July 29, 2025, to consider and approve the un-audited financial results (standalone and consolidated) of the Company for the quarter ended June 30, 2025, amongst other matters. Further, as per provisions of the Company's Code of Conduct for Prohibition of Insider Trading, trading window for Designated Persons of the Company is closed from July 1, 2025 and shall open after 48 hrs post declaration of financial results by the Company.
